# Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA

> **NCT03561649** · NA · COMPLETED · sponsor: **University Hospital, Grenoble** · enrollment: 50 (actual)

## Conditions studied

- Spondylitis, Ankylosing

## Interventions

- **DRUG:** Adalimumab

## Key facts

- **NCT ID:** NCT03561649
- **Lead sponsor:** University Hospital, Grenoble
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-14
- **Primary completion:** 2019-12-14
- **Final completion:** 2020-05-07
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-03-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03561649

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03561649, "Prediction of Treatment Response at 6 Months by Combinatorial Analysis of Serum Biomarkers in Biotherapy Naive SpA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03561649. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*